Clinical comparison study to evaluate the efficacy between tourniquet for blocking peripheral blood flow in primary total knee arthroplasty

Clinical comparison study to evaluate the efficacy between tourniquet for blocking peripheral blood flow with minimal pressure sensor in primary total knee arthroplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003149

Enrollment

Registered

2018-08-30

Start date

2016-06-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In patients undergoing total knee arthroplasty, the validity of tourniquet using limb occlusion pressure and elastic cuff was verified through clinical trials. For patients undergo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criterion was patients with primary osteoarthritis between 50 and 80 years old who were scheduled for primary TKA

Exclusion criteria

Exclusion criteria: patients below 50, and over 81 years of age patients on antiplatelets patients with coagulopathy disease patients with a history of DVT patients with peripheral nerve palsy patients who underwent surgery of the lower limb patients with a history of past psychological illness alcoholics patients diagnosed with cancerous condition patients Participating in other studies patients with Parkinson's disease, sequelae of poliomyelitis, stroke, and other conditions that may affect postoperative outcomes patient with diseases where the risk of surgery is high due to accompanying cardiopulmonary and other systemic diseases patietns with fracture or deformation of the joint that is severe and requires bone grafting, block or long stem operation patients on alcohol medication and medication Patients with diagnosed cancer

Design outcomes

Primary

Measure	Time frame
Knee joint - Visual Analogue Scale (VAS)	—

Secondary

Measure	Time frame
hemoglobin;hematocrit;creatine phosphokinase;lactate dehydrogenase	—

Countries

Korea, Republic of

Contacts

Public ContactHan Soo

Seoul National University Hospital

oshawks7@gmail.com+82-2-2072-4060

Outcome results